Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,Inverse variance weighted,22,1.00 [0.97-1.04],0.928570013238297
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,Inverse variance weighted,22,1.01 [0.98-1.04],0.355080001988747
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,Inverse variance weighted,22,1.01 [0.98-1.03],0.69761107316602
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,Inverse variance weighted,22,0.97 [0.70-1.34],0.846116306964471
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,Other septicaemia,Inverse variance weighted,22,1.02 [0.97-1.07],0.487530264742918
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,Inverse variance weighted,22,0.80 [0.52-1.22],0.303877276312609
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,Inverse variance weighted,22,1.08 [1.02-1.15],0.0138881503820136
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",Inverse variance weighted,22,0.90 [0.74-1.10],0.312659677302888
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",Inverse variance weighted,22,1.00 [0.90-1.11],0.992078600553198
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",Inverse variance weighted,22,1.13 [0.94-1.37],0.19701475207216
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",Inverse variance weighted,22,0.99 [0.85-1.16],0.897215874893
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,Inverse variance weighted,22,0.89 [0.82-0.98],0.0161619566658872
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,Inverse variance weighted,22,1.01 [0.96-1.07],0.617834038058778
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,Inverse variance weighted,22,1.05 [1.00-1.10],0.0517423718602632
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,Inverse variance weighted,22,0.85 [0.68-1.05],0.135931563913527
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,Inverse variance weighted,22,0.87 [0.64-1.19],0.377786248737412
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,Inverse variance weighted,22,0.91 [0.84-0.99],0.0345019191281581
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,Inverse variance weighted,22,1.06 [0.97-1.15],0.194434615961003
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",Inverse variance weighted,22,0.84 [0.74-0.95],0.0048914783289979
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,Inverse variance weighted,22,0.95 [0.75-1.21],0.675033425874536
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,Inverse variance weighted,22,1.14 [1.01-1.29],0.0296623453372046
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",Inverse variance weighted,22,1.00 [0.94-1.05],0.869832811488795
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,Inverse variance weighted,22,1.01 [0.91-1.12],0.895390764979701
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,Inverse variance weighted,22,0.98 [0.86-1.13],0.805776651433077
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,22,1.01 [0.98-1.03],0.642881624437108
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",Inverse variance weighted,22,0.98 [0.66-1.45],0.91472655131947
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,Inverse variance weighted,22,1.00 [0.97-1.03],0.90817040475754
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,Inverse variance weighted,22,1.05 [0.81-1.35],0.70668031208704
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,Inverse variance weighted,22,1.04 [0.94-1.15],0.491597309423536
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",Inverse variance weighted,22,1.04 [0.97-1.12],0.244866425869127
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",Inverse variance weighted,22,1.00 [0.93-1.08],0.934113171050593
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,Inverse variance weighted,22,1.01 [0.98-1.04],0.569405596096624
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,22,1.00 [0.96-1.04],0.975643604267735
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",Inverse variance weighted,22,1.01 [0.96-1.06],0.801199609760198
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,Cardiac arrest,Inverse variance weighted,22,1.11 [0.99-1.25],0.0727659452916296
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,"Heart failure, strict",Inverse variance weighted,22,1.03 [1.00-1.07],0.0783612936416835
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,Hypotension,Inverse variance weighted,22,1.00 [0.93-1.09],0.920100436843477
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,Inverse variance weighted,22,0.86 [0.73-1.01],0.0682513480904082
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,Death due to cardiac causes,Inverse variance weighted,22,1.00 [0.95-1.06],0.857085010886367
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,Inverse variance weighted,22,1.10 [0.95-1.26],0.198791236426839
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,Inverse variance weighted,22,0.85 [0.73-1.01],0.0612744639792793
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,Inverse variance weighted,22,1.05 [0.93-1.19],0.411334043932516
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,Secondary right heart disease,Inverse variance weighted,22,1.03 [0.88-1.21],0.679723581092667
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter IX Diseases of the circulatory system,Oesophageal varices,Inverse variance weighted,22,0.91 [0.77-1.07],0.239512974140165
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,Interstitial lung disease,Inverse variance weighted,22,1.02 [0.94-1.11],0.604199368675169
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,All influenza (not pneumonia),Inverse variance weighted,22,0.99 [0.92-1.07],0.838338029980291
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,Inverse variance weighted,22,1.01 [0.90-1.14],0.865036464156834
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,Inverse variance weighted,22,0.95 [0.88-1.03],0.234194164001192
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,Bronchiectasis,Inverse variance weighted,22,1.01 [0.90-1.13],0.872684466551429
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,Emphysema,Inverse variance weighted,22,1.01 [0.90-1.14],0.832281957494033
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,All influenza,Inverse variance weighted,22,1.01 [0.95-1.07],0.720448512544926
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,Influenza and pneumonia,Inverse variance weighted,22,1.01 [0.99-1.03],0.484719441661731
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,Inverse variance weighted,22,0.99 [0.96-1.02],0.63030702136623
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,Inverse variance weighted,22,1.00 [0.96-1.04],0.96061878694962
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,Other diseases of pleura,Inverse variance weighted,22,0.98 [0.94-1.02],0.386329283377456
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter X Diseases of the respiratory system,Pleural effusion,Inverse variance weighted,22,0.93 [0.86-1.01],0.0720802141303268
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,Cholelithiasis,Inverse variance weighted,22,1.00 [0.97-1.04],0.894669626364554
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,Coeliac disease,Inverse variance weighted,22,1.01 [0.93-1.11],0.748052174089511
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,Other diseases of liver,Inverse variance weighted,22,0.88 [0.81-0.95],0.0015596519052426
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,Inverse variance weighted,22,0.98 [0.86-1.10],0.714373054721281
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,Diseases of liver,Inverse variance weighted,22,0.94 [0.89-0.99],0.0288972317486843
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,Intestinal malabsorption,Inverse variance weighted,22,0.99 [0.84-1.17],0.895370027257202
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",Inverse variance weighted,22,1.03 [1.00-1.05],0.0555340611624873
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,Diseases of the digestive system,Inverse variance weighted,22,0.98 [0.94-1.02],0.280318132972694
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,Inverse variance weighted,22,1.04 [0.92-1.18],0.489881974045358
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),Inverse variance weighted,22,1.04 [0.98-1.11],0.194676737721606
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,Inverse variance weighted,22,0.94 [0.84-1.07],0.359450182238944
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,Inverse variance weighted,22,1.04 [0.98-1.11],0.186977965520702
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,Inverse variance weighted,22,1.05 [0.92-1.20],0.488568012718005
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,Inverse variance weighted,22,1.03 [0.99-1.07],0.143470717553084
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,Inverse variance weighted,22,1.02 [0.97-1.07],0.424475802084867
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",Inverse variance weighted,22,1.07 [0.98-1.18],0.141761377313162
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,Inverse variance weighted,22,1.00 [0.94-1.07],0.89707602976948
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,Inverse variance weighted,22,1.03 [1.00-1.06],0.0867742251136799
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,Inverse variance weighted,22,1.03 [0.98-1.09],0.271620972956918
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],Inverse variance weighted,22,0.94 [0.84-1.04],0.230822301374222
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,Acute renal failure,Inverse variance weighted,22,1.00 [0.93-1.07],0.975147742878455
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,Inverse variance weighted,22,0.98 [0.82-1.17],0.818140404633102
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,Inverse variance weighted,22,1.01 [0.95-1.07],0.807710132504038
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,Dialysis,Inverse variance weighted,22,0.92 [0.78-1.08],0.298893973725709
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,Inverse variance weighted,22,1.06 [0.97-1.16],0.196641181321292
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,Inverse variance weighted,22,1.00 [0.92-1.09],0.988256985017717
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,Inverse variance weighted,22,1.02 [0.99-1.05],0.232556528061356
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,Inverse variance weighted,22,0.97 [0.87-1.08],0.598148660780411
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,Inverse variance weighted,22,1.01 [0.97-1.05],0.567902821591904
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,Inverse variance weighted,22,1.02 [0.99-1.05],0.19553200375294
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,Inverse variance weighted,22,1.04 [0.95-1.14],0.381181798601342
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",Inverse variance weighted,22,1.03 [0.96-1.11],0.364324535120926
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,Inverse variance weighted,22,1.00 [0.94-1.08],0.891418321501006
GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",Inverse variance weighted,22,1.01 [0.94-1.08],0.830552687604598
